These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 2626520

  • 1. Plasma levels of parent drug and metabolites in patients receiving oral and depot fluphenazine.
    Marder SR, Van Putten T, Aravagiri M, Hubbard JW, Hawes EM, McKay G, Midha KK.
    Psychopharmacol Bull; 1989; 25(3):479-82. PubMed ID: 2626520
    [Abstract] [Full Text] [Related]

  • 2. Plasma levels of neuroleptic in patients receiving depot fluphenazine.
    Cohen BM, Waternaux C, Chouinard G, Sommer BR, Jones B.
    J Clin Psychopharmacol; 1985 Dec; 5(6):328-32. PubMed ID: 4066997
    [Abstract] [Full Text] [Related]

  • 3. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK, Hubbard JW, Marder SR, Marshall BD, Van Putten T.
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Plasma fluphenazine levels and clinical response in newly admitted schizophrenic patients.
    Van Putten T, Aravagiri M, Marder SR, Wirshing WC, Mintz J, Chabert N.
    Psychopharmacol Bull; 1991 Jul; 27(2):91-6. PubMed ID: 1924666
    [Abstract] [Full Text] [Related]

  • 6. Radioimmunoassay for 7-hydroxy metabolite of fluphenazine and its application to plasma level monitoring in schizophrenic patients treated long term with oral and depot fluphenazine.
    Aravagiri M, Marder SR, Van Putten T, Hawes EM, McKay G, Midha KK.
    Ther Drug Monit; 1994 Feb; 16(1):21-9. PubMed ID: 8160250
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Low neuroleptic serum levels in patients receiving fluphenazine decanoate.
    Tune LE, Creese I, Coyle JT, Pearlson G, Snyder SH.
    Am J Psychiatry; 1980 Jan; 137(1):80-2. PubMed ID: 6101523
    [Abstract] [Full Text] [Related]

  • 9. Fluphenazine blood levels and clinical response.
    Harris PQ, Friedman MJ, Cohen BM, Cooper TB.
    Biol Psychiatry; 1982 Oct; 17(10):1123-30. PubMed ID: 7171656
    [Abstract] [Full Text] [Related]

  • 10. The initiation of long-term pharmacotherapy in schizophrenia: dosage and side effect comparisons between oral and depot fluphenazine.
    Schooler NR, Levine J.
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jul; 9(4):159-69. PubMed ID: 790413
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relapse in chronic schizophrenics treated with fluphenazine decanoate is associated with low serum neuroleptic levels.
    Jayaram G, Coyle J, Tune L.
    J Clin Psychiatry; 1986 May; 47(5):247-8. PubMed ID: 3700342
    [Abstract] [Full Text] [Related]

  • 16. [Characteristics of the therapeutic action fluphenzaine decanoate (moditen-depot) in schizophrenia].
    Tsutsul'kovskaia MIa, Minsker EI, Panteleeva GP, Mazurskii MB, Pekunova LG.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973 May; 73(5):753-8. PubMed ID: 4718619
    [No Abstract] [Full Text] [Related]

  • 17. Neuroleptic serum levels measured by radioreceptor assay in patients receiving intramuscular depot neuroleptics. Some preliminary findings.
    Turbott J, Villiger J, Hunter L.
    Br J Psychiatry; 1985 Apr; 146():439-42. PubMed ID: 4016448
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.